.It's an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Therapi...
.Atea Pharmaceuticals' antiviral has actually stopped working yet another COVID-19 trial, but the bi...
.Neurocrine Biosciences' mental illness system pivot has fallen short. The biotech was unable to dup...
.Sanofi has made a late access to the radioligand gathering, paying one hundred million europeans ($...
.After F2G's initial effort to obtain a brand-new lesson of antifungal to market was actually thwart...
.Moderna has promised to reduce R&D spending by $1.1 billion through 2027. The choice to retract ...
.Just 4 months after Sanofi wager $80 million in upfront cash money on Pivot Therapies' losmapimod, ...
.Cancer provider Oncternal Therapies is folding all its own scientific tests and also laying off per...
.Roche is storing out hopes that its own injectable being overweight prospect could inevitably demon...
.Novo Nordisk has raised the top on a phase 1 test of its own oral amylin and also GLP-1 receptor co...